| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/27/2006 | US7067554 Method for the synthesis of compounds of formula I and their uses thereof |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067546 high yield, industrial scale crystallization of 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (Candesartan) from solution or suspension with an aprotic polar solvent, between zero and 30 degrees Celsius |
| 06/27/2006 | US7067543 Anthranilic acid amides and pharmaceutical use thereof |
| 06/27/2006 | US7067542 Diaminediols for the treatment of Alzheimer's disease |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067538 monocyte chemoattractant protein-1; a bis(phenyl) sulfonyl or sulfonamido ketone or dihydroxy compound; antiinflammatory, anticholesterol, antiarthritic agents; immunotherapy; transplant rejection |
| 06/27/2006 | US7067535 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 06/27/2006 | US7067533 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 06/27/2006 | US7067528 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol |
| 06/27/2006 | US7067520 Antidiabetic agents; hypoglycemic agents; antilipemic agents; dietetics |
| 06/27/2006 | US7067519 human orexin receptor antagonists; analgesics, antidiabetic agents; sleep apnea, insomnia |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss |
| 06/27/2006 | US7067507 Macrocycles useful in the treatment of Alzheimer's disease |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067484 AL-1 neurotrophic factor treatments |
| 06/27/2006 | US7067304 Monascus purpureus mutants and their use in preparing fermentation products having blood pressure lowering activity |
| 06/27/2006 | US7067285 Desaturase genes and uses thereof |
| 06/27/2006 | US7067281 Mammalian IAP gene family, primers, probes and detection methods |
| 06/27/2006 | US7067276 administering a cytotoxic compound of porphyrin complexed with a radioactive metal to a mammal; treating arteriosclerotic lesions; radioactive metal is cytotoxic to cells in and surrounding the plaque |
| 06/27/2006 | US7067158 Preparation for the relief of disease |
| 06/27/2006 | US7067154 Pharmaceutical compositions containing Vitamin D and calcium, their preparation and therapeutic use |
| 06/27/2006 | US7067133 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/27/2006 | US7067121 Grafting heart tissue; closure of heart defect |
| 06/27/2006 | CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators |
| 06/22/2006 | WO2006065703A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 06/22/2006 | WO2006065277A2 Heterocyclic aspartyl protease inhibitors |
| 06/22/2006 | WO2006065216A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | WO2006065215A1 Novel compounds |
| 06/22/2006 | WO2006064889A1 Method for reduction, stabilization and prevention of rupture of lipid rich plaque |
| 06/22/2006 | WO2006064761A1 Adiponectin regultor and foods, drinks, food aditives and drugs containing the same |
| 06/22/2006 | WO2006064686A1 Drug and method for preventing or relieving delayed nerve cell death |
| 06/22/2006 | WO2006064484A1 Azabicyclononene derivatives as renin inhibitors |
| 06/22/2006 | WO2006064277A1 Silicon compounds and their use |
| 06/22/2006 | WO2006064263A1 Silicon compounds and their use |
| 06/22/2006 | WO2006064016A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and hmg coa reductase inhibitors |
| 06/22/2006 | WO2006063974A2 Il-15 antigen arrays and uses thereof |
| 06/22/2006 | WO2006063812A1 3-cycloalkyl-1,2,4-triazin-5(2h)-ones |
| 06/22/2006 | WO2006063811A2 Substituted 1,2,4-triazin-5(2h)-ones |
| 06/22/2006 | WO2006063805A1 3-amino-pyrazolo[3,4b]pyridines used as inhibitors of protein tyrosine kinases for treating angiogenic, hyperproliferative or neurodegenerative diseases |
| 06/22/2006 | WO2006063737A1 Combination therapy comprising telmisartan and hydrochlorothiazide |
| 06/22/2006 | WO2006063715A1 Use of ppar agonists for the treatment of congestive heart failure |
| 06/22/2006 | WO2006063610A1 Heteroaryl substituted diazabicyclononene derivatives |
| 06/22/2006 | WO2006063446A1 Methods of cardioprotection using dichloroacetate in combination with an inotrope |
| 06/22/2006 | WO2006063408A1 Compositions and methods for treating cardiovascular disorders |
| 06/22/2006 | WO2006051314A3 Guanidine derivatives as inhibitors of ddah |
| 06/22/2006 | WO2006034832A3 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 06/22/2006 | WO2006034232A3 Diagnostic marker |
| 06/22/2006 | WO2006028904A9 Quinazolines useful as modulators of ion channels |
| 06/22/2006 | WO2006026380A3 Geranylgeranyl pyrophosphate synthase inhibitors |
| 06/22/2006 | WO2003061655A8 2-aminothiazole allosteric enhancers of a1 adenosine receptors |
| 06/22/2006 | US20060136136 Crystal structure of baff, and use thereof in drug design |
| 06/22/2006 | US20060135812 Thiol-based NAALADase inhibitors |
| 06/22/2006 | US20060135785 Alpha-phenyl acetanilide derivatives having an acat inhibiting activity and the therapeutic application thereof |
| 06/22/2006 | US20060135749 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 06/22/2006 | US20060135614 Novel compounds |
| 06/22/2006 | US20060135613 Carboxamides derivatives |
| 06/22/2006 | US20060135611 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/22/2006 | US20060135607 Drug for improving prognosis for subarachnoid hemorrhage |
| 06/22/2006 | US20060135602 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfphonates) and compositions containing same |
| 06/22/2006 | US20060135590 Selected fused pyrrolocarbazoles |
| 06/22/2006 | US20060135587 Method and compounds for promoting healing and reducing inflammation |
| 06/22/2006 | US20060135580 One step reaction of compound such as 3,5-dimethyl-isoxazole with butlyllithium and (3,5-di-tert-butyl)-4-hydroxybenzaldehyde, recrystallization/dehydration alcohol in the presence of a base to give (E)-5-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)vinyl]-3-methylisoxazole |
| 06/22/2006 | US20060135578 Five-membered heterocyclic compounds |
| 06/22/2006 | US20060135577 EDG (Endothelial differentiation gene)-2 antagonist; chronic asthma, glomerular nephritis, obesity, prostate hyperplasia, arteriosclerosis, atopic dermatitis; (1) 3-(N-((2-(2-((4-chlorobenzylamino)carbonyl)phenyl)phenyl)carbonyl)-N-(2-(2-methoxyphenyl)ethyl)amino)propanoic acid |
| 06/22/2006 | US20060135569 Use of benzisoselenazolone compounds against ischemic myocardial damage |
| 06/22/2006 | US20060135566 E.g., N-[5-(2-Benzoylamino-4-pyridyl)-4-(3,5-dimethylphenyl)-1,3-thiazol-2-yl]acetamide,; the compounds have adenosine A3 receptor antagonistic activity, a p38 MAP kinase inhibitory action, and a TNF- alpha production-inhibitory action |
| 06/22/2006 | US20060135560 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/22/2006 | US20060135536 Ion channel modulating activity I |
| 06/22/2006 | US20060135534 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/22/2006 | US20060135523 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/22/2006 | US20060135508 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | US20060135482 Use of fosinopril to reduce cardiovascular events in disalysis patients |
| 06/22/2006 | US20060135452 Injecting a naked plasmid DNA encoding an angiogenic growth factor such as hepatocyte growth factor, vascular endothelial growth factor, fibroblast growth factor, and nitric oxide synthase into a muscle under conditions of increased pressure inside the muscle, particularly hyperbaric oxygen therapy |
| 06/22/2006 | US20060134303 Adding fatty acid ester, a fatty acid amide, a free fatty acid or a hydrocarbon, to a mixture of a fat or an oil, being edible or for use in cosmetics; stripping and separating the environmental pollutant present in the fat or oil |
| 06/22/2006 | US20060134208 Controlled release and taste masking oral pharmaceutical composition |
| 06/22/2006 | US20060134167 Administering to the cardiac tissue an angiogenic thrombin derivative peptide and/or inhibiting vascular occulsion or restenosis and stimulating revascularization |
| 06/22/2006 | US20060134144 Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof |
| 06/22/2006 | US20060134089 Nitric oxide synthase gene transfer to the atrium for vagal tone increase |
| 06/22/2006 | US20060134085 Compositions containing coenzyme q10 |
| 06/22/2006 | DE102004061017A1 Piperidinsulfonylharnstoffe und -thioharnstoffe, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Piperidinsulfonylharnstoffe and thioureas, their preparation, their use and pharmaceutical compositions containing them |
| 06/22/2006 | DE102004061009A1 Substituierte 1,2,4-Triazin-5(2H)-one Substituted 1,2,4-triazine-5 (2H) -ones |
| 06/22/2006 | DE102004061008A1 3-Arylalkyl- und 3-Heteroarylalkyl-substituierte 1,2,4-Triazin-5(2H)-one 3-arylalkyl and heteroarylalkyl 3-substituted-1,2,4-triazine-5 (2H) -ones |
| 06/22/2006 | DE102004061006A1 3-Benzylthio-1,2,4-triazin-5(2H)-one 3-benzylthio-1,2,4-triazin-5 (2H) -ones |
| 06/22/2006 | DE102004061005A1 3-Cycloalkyl-1,2,4-triazin-5(2H)-one 3-cycloalkyl-1,2,4-triazin-5 (2H) -ones |
| 06/22/2006 | DE102004061003A1 New (5'S)-4'-cyclopentyl-3'-((S)-fluoro(4-(trifluormethyl)phenyl)meth yl)-2'-isopropyl-5',8'-dihydro-6'H-spiro(cyclobutane-1,T-quinoline)- 5'-ol is cholesterol transfer protein inhibitor useful for treating e.g. dyslipidemia and stroke |
| 06/22/2006 | DE102004061002A1 New (5'S)-2',4'-dicyclopentyl -3'-9(S)-fluoro(4-(trifluoromethyl) phenyl)methyl)-5',8' -dihydro-6'H-spiro(cyclopropane-1,7'-quinoline)- 5'-ol is a cholesterol ester transfer protein inhibitor useful for treating e.g. coronary heart diseases |
| 06/22/2006 | DE102004061001A1 New spiro-cyclohexyl-pyridine compound is cholesterol ester transfer protein inhibitor useful to treat and/or prevent coronary heart diseases, hypolipoproteinemia, dyslipidemia, hypertriglyceridemia, hyperlipidemia, restenosis and obesity |
| 06/22/2006 | DE102004061000A1 New tetrahydroquinoline compounds are cholesterol ester transfer protein inhibitors useful for primary and/or secondary prevention of coronary heart disease; and for treatment and/or prevention of e.g. hypolipoproteinemia and dyslipidemia |
| 06/22/2006 | DE102004060999A1 New (S)-4-cyclohexyl-3-((S)-fluoro-(4-trifluoromethyl-phenyl)-methyl) -2-isopropyl-7,7-dimethyl-5,6,7,8-tetrahydro-quinolin-5-ol is cholesterol ester transfer protein inhibitor useful e.g. to treat coronary heart disease |
| 06/22/2006 | DE102004060998A1 New 2,4-dicyclopentyl-3-(fluoro-(4-trifluoromethyl-phenyl)-methyl)-7, 7-dimethyl-5,6,7,8-tetrahydro-quinolin-5-ol compound is cholesterol ester transfer protein inhibitor useful to treat and/or prevent e.g. coronary heart diseases |